Responding to reports from peer reviewers is a crucial part of scientific publishing, but early-career researchers are rarely taught about this process.
Even as you read this sentence, the brain cells you are using to process it might be mutating. What if these changes could be ...
CAR T cell therapy wipes out rogue antibodies' source and improves walking speed in people with the same autoimmune disorder ...
Approval for Xeltis’s aXess device was based on pivotal trial data that demonstrated 79% secondary patency and a patency-related reintervention rate of 1.3 per patient year.
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American ...
The startup is working with two major federal research agencies as it develops a platform for observing molecular activity as it unfolds, rather than through a static image.
The Netflix docuseries unpacks the personal life of the WWE icon but shows he was always living the gimmick outside the ring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results